Itamar Shalit
CEO
Microbiology
Infect-ERA
Romania
Biography
Itamar Shalit is currently the CEO of the Galilee Biomedical Research Administration, a government-sponsored initiative to promote and support biomedical research in the hospitals of Northern Israel. During the years 2001 - 2012 he was the Director of the Pediatric Infectious Disease Unit at the Schneider Children’s Medical Center of Israel. He is one of the founders and board member of NasVax Ltd., a company that develops improved immunotherapeutic products. His scientific activities include immune modulation of quinolones, infections in immune-compromised hosts as well as new targets and new drug combinations to treat invasive fungal infections. He is also a member of the Advisory Committee on Infectious Diseases and Immunization and of the Committee for Eradication of Polio and Eradication of Measles and Rubella of the Israeli Ministry of Health.
Research Interest
Microbiology